Eric Espinosa
Overview
Explore the profile of Eric Espinosa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
889
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Battut L, Leveque E, Valitutti S, Cenac N, Dietrich G, Espinosa E
Front Immunol
. 2024 Oct;
15:1470546.
PMID: 39416773
Interleukin-33 (IL-33) is an alarmin released by epithelial cells in response to tissue damage. It activates resident immune sentinel cells, which then produce signals commonly associated with type 2 immune...
2.
Espinosa E
J Leukoc Biol
. 2024 Oct;
116(6):1217-1219.
PMID: 39378340
A recent article in Cell reported a new peculiar interaction between mast cells (MCs) and neutrophils. Upon IgE/Ag-mediated degranulation, MCs produce leukotriene B4, which attracts migrating neutrophils. Some neutrophils are...
3.
Leveque E, Battut L, Petitfils C, Valitutti S, Cenac N, Dietrich G, et al.
J Leukoc Biol
. 2024 Jun;
116(5):1127-1141.
PMID: 38916515
Effector CD4+ T (Teff) lymphocytes infiltrate sites of inflammation and orchestrate the immune response by instructing local leukocytes. Mast cells (MCs) are tissue sentinel cells strategically located near blood vessels...
4.
Mas-Orea X, Rey L, Battut L, Bories C, Petitfils C, Abot A, et al.
Commun Biol
. 2023 Nov;
6(1):1168.
PMID: 37968381
Opioid-dependent immune-mediated analgesic effects have been broadly reported upon inflammation. In preclinical mouse models of intestinal inflammatory diseases, the local release of enkephalins (endogenous opioids) by colitogenic T lymphocytes alleviate...
5.
Ramos-Llorca A, Decraecker L, Cacheux V, Zeiburlina I, De Bruyn M, Battut L, et al.
Front Chem
. 2023 Jan;
10:1089959.
PMID: 36688031
Activity-based probes (ABP) are molecules that bind covalently to the active form of an enzyme family, making them an attractive tool for target and biomarker identification and drug discovery. The...
6.
Laoubi L, Lacoffrette M, Valsesia S, Lenief V, Guironnet-Paquet A, Mosnier A, et al.
J Allergy Clin Immunol
. 2022 Jul;
150(5):1194-1208.
PMID: 35779666
Background: Epicutaneous immunotherapy (EPIT) protocols have recently been developed to restore tolerance in patients with food allergy. The mechanisms by which EPIT protocols promote desensitization rely on a profound immune...
7.
Leveque E, Rouch A, Syrykh C, Mazieres J, Brouchet L, Valitutti S, et al.
Cancers (Basel)
. 2022 Mar;
14(6).
PMID: 35326546
Mast cells (MCs) are multifaceted innate immune cells often present in the tumor microenvironment (TME). However, MCs have been only barely characterized in studies focusing on global immune infiltrate phenotyping....
8.
Eliasse Y, Leveque E, Garidou L, Battut L, McKenzie B, Nocera T, et al.
Front Immunol
. 2021 Oct;
12:740540.
PMID: 34650562
Acne is a multifactorial disease driven by physiological changes occurring during puberty in the pilosebaceous unit (PSU) that leads to sebum overproduction and a dysbiosis involving notably . These changes...
9.
Lafouresse F, Jugele R, Muller S, Doineau M, Duplan-Eche V, Espinosa E, et al.
Elife
. 2021 Jan;
10.
PMID: 33427199
Cytotoxic immune cells are endowed with a high degree of heterogeneity in their lytic function, but how this heterogeneity is generated is still an open question. We therefore investigated if...
10.
Domagala M, Laplagne C, Leveque E, Laurent C, Fournie J, Espinosa E, et al.
Cancers (Basel)
. 2021 Jan;
13(2).
PMID: 33418996
Interactions between malignant cells and neighboring stromal and immune cells profoundly shape cancer progression. New forms of therapies targeting these cells have revolutionized the treatment of cancer. However, in order...